ESMO posted on LinkedIn:
“New ESMO Clinical Practice Guideline on Rare Endocrine Tumors: Evidence-based recommendations on imaging, diagnosis, treatment and follow-up of neuroendocrine, parathyroid and intrathyroid thymic neoplasms by experts across Europe.”
Read Further.
Source: ESMO/LinkedIn